The FDA's foreign inspections of drug manufacturers have not returned to pre-pandemic levels.

The Food and Drug Administration (FDA) inspects drug manufacturers both here and abroad to ensure the safety and quality of drugs sold in the United States. But the FDA paused many of its in-person inspection efforts during COVID-19 due to travel restrictions.

⚙Content automatically machine-translated.

Debates 0

Be the first to contribute to the debate.

Share your information and promote your argument

Do not hesitate to publish information or data that may be positive or useful.

To join the debate, log in or create a free account.

Sign in Create account